Inventor · disambiguated record
Jeffrey H. Hager
Also filed as: HAGER JEFFREY · HAGER JEFFREY H
9 granted patents·3 pending applications·76 citations·filing 2006–2021
87Inventor score
Top patents by PatentIndex Score
12 records- 0196US9475798B2Azetidine estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2015·Granted Oct 25, 2016·20 cites·14 claims
- 0294US9340524B2Androgen receptor modulator and uses thereofARAGON PHARMACEUTICALS INC·Filed 2014·Granted May 17, 2016·25 cites·4 claims
- 0391US9873684B2Estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2015·Granted Jan 23, 2018·11 cites·16 claims
- 0491US9655880B2Azetidine estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2016·Granted May 23, 2017·5 cites·18 claims
- 0588US9675586B2Estrogen receptor modulator for the treatment of locally advanced or metastatic estrogen receptor positive breast cancerGENENTECH INC·Filed 2014·Granted Jun 13, 2017·9 cites·11 claims
- 0678US9617602B2Methods and compositions for determining resistance to androgen receptor therapyARAGON PHARMACEUTICALS INC·Filed 2013·Granted Apr 11, 2017·6 cites·31 claims
- 0765US2021177821A1Androgen Receptor Modulator And Uses ThereofARAGON PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0857US10034860B2Estrogen receptor modulator for the treatment of locally advanced or metastatic estrogen receptor positive breast cancerGENENTECH INC·Filed 2017·Granted Jul 31, 2018·0 cites·12 claims
- 0956US2016220548A1Androgen receptor modulator and uses thereofARAGON PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1054US10227334B2Estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2017·Granted Mar 12, 2019·0 cites·2 claims
- 1141US7785813B2Prefoldin 4 in the treatment and diagnosis of cancerUNIV CALIFORNIA·Filed 2006·Granted Aug 31, 2010·0 cites·2 claims
- 1240US2017196840A1Methods and compositions for determining resistance to androgen receptor therapyARAGON PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →